{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:08:07Z","timestamp":1787501287041,"version":"build-2736575974"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,22]],"date-time":"2023-04-22T00:00:00Z","timestamp":1682121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,22]],"date-time":"2023-04-22T00:00:00Z","timestamp":1682121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17K16944"],"award-info":[{"award-number":["17K16944"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["18K16869"],"award-info":[{"award-number":["18K16869"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Hospital Organization of Japan","award":["R3-NHO (kankakuki)-02"],"award-info":[{"award-number":["R3-NHO (kankakuki)-02"]}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["20FC1057"],"award-info":[{"award-number":["20FC1057"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Japan Agency for Mdical Research and Development","award":["22gk0110063h0001"],"award-info":[{"award-number":["22gk0110063h0001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:italic>NF2<\/jats:italic>\n                    -related schwannomatosis (NF2) is an autosomal dominant genetic disorder caused by variants in the\n                    <jats:italic>NF2<\/jats:italic>\n                    gene. Approximately 50% of NF2 patients inherit pathogenic variants, and the remainder acquire de novo variants. NF2 is characterized by development of bilateral vestibular schwannomas. The genetic background of Japanese NF2 cases has not been fully investigated, and the present report performed a genetic analysis of 14 Japanese NF2 cases and examined genotype\u2013phenotype correlations. DNA samples collected from peripheral blood were analyzed by next-generation sequencing, multiplex ligation-dependent probe amplification analysis, and in vitro electrophoresis. Ten cases had pathogenic or likely pathogenic variants in the\n                    <jats:italic>NF2<\/jats:italic>\n                    gene, with seven truncating variants and three non-truncating variants. The age of onset in all seven cases with truncating variants was\u2009&lt;\u200920\u00a0years. The age of onset significantly differed among cases with truncating\n                    <jats:italic>NF2<\/jats:italic>\n                    variants, non-truncating\n                    <jats:italic>NF2<\/jats:italic>\n                    variants, and no\n                    <jats:italic>NF2<\/jats:italic>\n                    variants. However, the clinical course of tumor growth and hearing deterioration were not predicted only by germline pathogenic\n                    <jats:italic>NF2<\/jats:italic>\n                    variants. The rate of truncating variants was higher in the present study than that of previous reports. Genotype\u2013phenotype correlations in the age of onset were present in the analyzed Japanese NF2 cases.\n                  <\/jats:p>","DOI":"10.1038\/s41598-023-33812-w","type":"journal-article","created":{"date-parts":[[2023,4,22]],"date-time":"2023-04-22T06:02:08Z","timestamp":1682143328000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Correlation between genotype and phenotype with special attention to hearing in 14 Japanese cases of NF2-related schwannomatosis"],"prefix":"10.1038","volume":"13","author":[{"given":"Naoki","family":"Oishi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Noguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Fujioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyomitsu","family":"Nara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Wasano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Mutai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rie","family":"Kawakita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Karatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukina","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Toda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Ozawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuo","family":"Matsunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,22]]},"reference":[{"key":"33812_CR1","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1136\/jmg.29.12.841","volume":"29","author":"DG Evans","year":"1992","unstructured":"Evans, D. G. et al. A genetic study of type 2 neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity. J. Med. Genet. 29, 841\u2013846 (1992).","journal-title":"J. Med. Genet."},{"key":"33812_CR2","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1016\/S0140-6736(09)60259-2","volume":"373","author":"AR Asthagiri","year":"2009","unstructured":"Asthagiri, A. R. et al. Neurofibromatosis type 2. Lancet 373, 1974\u20131986 (2009).","journal-title":"Lancet"},{"key":"33812_CR3","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1016\/j.gim.2022.05.007","volume":"24","author":"SR Plotkin","year":"2022","unstructured":"Plotkin, S. R. et al. Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation. Genet. Med. 24, 1967\u20131977 (2022).","journal-title":"Genet. Med."},{"key":"33812_CR4","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1136\/jnnp-2018-318538","volume":"89","author":"DG Evans","year":"2018","unstructured":"Evans, D. G. et al. Schwannomatosis: A genetic and epidemiological study. J Neurol. Neurosurg. Psychiatry 89, 1215\u20131219 (2018).","journal-title":"J Neurol. Neurosurg. Psychiatry"},{"key":"33812_CR5","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1001\/archotol.1980.00790360007003","volume":"106","author":"FH Linthicum Jr","year":"1980","unstructured":"Linthicum, F. H. Jr. & Brackmann, D. E. Bilateral acoustic tumors. A diagnostic and surgical challenge. Arch. Otolaryngol. 106, 729\u2013733 (1980).","journal-title":"Arch. Otolaryngol."},{"key":"33812_CR6","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3109\/00016489109130447","volume":"487","author":"T Matsunaga","year":"1991","unstructured":"Matsunaga, T., Igarashi, M. & Kanzaki, J. Temporal bone pathology of acoustic neurinoma (unilateral and bilateral) in relation to the internal auditory canal surgery. Acta Otolaryngol. Suppl. 487, 61\u201368 (1991).","journal-title":"Acta Otolaryngol. Suppl."},{"key":"33812_CR7","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1002\/lary.21822","volume":"121","author":"SI Nam","year":"2011","unstructured":"Nam, S. I., Linthicum, F. H. Jr. & Merchant, S. N. Temporal bone histopathology in neurofibromatosis type 2. Laryngoscope 121, 1548\u20131554 (2011).","journal-title":"Laryngoscope"},{"key":"33812_CR8","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1046\/j.1365-2273.2000.00421.x","volume":"25","author":"A Kishore","year":"2000","unstructured":"Kishore, A. & O\u2019Reilly, B. F. A clinical study of vestibular schwannomas in type 2 neurofibromatosis. Clin. Otolaryngol. Allied Sci. 25, 561\u2013565 (2000).","journal-title":"Clin. Otolaryngol. Allied Sci."},{"key":"33812_CR9","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1177\/0194599815573223","volume":"153","author":"H Mahboubi","year":"2015","unstructured":"Mahboubi, H. et al. Vestibular schwannoma excision in sporadic versus neurofibromatosis type 2 populations. Otolaryngol. Head Neck Surg. 153, 822\u2013831 (2015).","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"33812_CR10","first-page":"4","volume":"19","author":"DG Evans","year":"2009","unstructured":"Evans, D. G. Neurofibromatosis type 2 (NF2): a clinical and molecular review. Orphanet J. Rare Dis. 19, 4\u201316 (2009).","journal-title":"Orphanet J. Rare Dis."},{"key":"33812_CR11","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1136\/jmedgenet-2017-104519","volume":"54","author":"D Halliday","year":"2017","unstructured":"Halliday, D. et al. Genetic severity score predicts clinical phenotype in NF2. J. Med. Genet. 54, 657\u2013664 (2017).","journal-title":"J. Med. Genet."},{"key":"33812_CR12","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41436-019-0598-7","volume":"22","author":"DG Evans","year":"2020","unstructured":"Evans, D. G. et al. Incidence of mosaicism in 1055 de novo NF2 cases: Much higher than previous estimates with high utility of next-generation sequencing. Genet. Med. 22, 53\u201359 (2020).","journal-title":"Genet. Med."},{"key":"33812_CR13","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1136\/jmg.35.6.450","volume":"35","author":"DG Evans","year":"1998","unstructured":"Evans, D. G., Trueman, L., Wallace, A., Collins, S. & Strachan, T. Genotype\/phenotype correlations in type 2 neurofibromatosis (NF2): Evidence for more severe disease associated with truncating mutations. J. Med. Genet. 35, 450\u2013455 (1998).","journal-title":"J. Med. Genet."},{"key":"33812_CR14","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1136\/jmedgenet-2020-106973","volume":"58","author":"Y Teranishi","year":"2020","unstructured":"Teranishi, Y. et al. Targeted deep sequencing of DNA from multiple tissue types improves the diagnostic rate and reveals a highly diverse phenotype of mosaic neurofibromatosis type 2. J. Med. Genet. 58, 701\u2013711 (2020).","journal-title":"J. Med. Genet."},{"key":"33812_CR15","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1136\/jmedgenet-2015-103290","volume":"52","author":"A Hexter","year":"2015","unstructured":"Hexter, A. et al. Clinical and molecular predictors of mortality in neurofibromatosis 2: A UK national analysis of 1192 patients. J. Med. Genet. 52, 699\u2013705 (2015).","journal-title":"J. Med. Genet."},{"key":"33812_CR16","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1086\/422700","volume":"75","author":"ME Baser","year":"2004","unstructured":"Baser, M. E. et al. Genotype-phenotype correlations for nervous system tumors in neurofibromatosis 2: A population-based study. Am. J. Hum. Genet. 75, 231\u2013239 (2004).","journal-title":"Am. J. Hum. Genet."},{"key":"33812_CR17","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1007\/s004390050255","volume":"98","author":"L Kluwe","year":"1996","unstructured":"Kluwe, L. et al. Identification of NF2 germline mutations and comparison with neurofibromatosis 2 phenotypes. Hum. Genet. 98, 534\u2013538 (1996).","journal-title":"Hum. Genet."},{"key":"33812_CR18","first-page":"529","volume":"59","author":"DM Parry","year":"1996","unstructured":"Parry, D. M. et al. Germline mutations in the neurofibromatosis 2 gene: Correlations with disease severity and retinal abnormalities. Am. J. Hum. Genet. 59, 529\u2013539 (1996).","journal-title":"Am. J. Hum. Genet."},{"key":"33812_CR19","doi-asserted-by":"publisher","first-page":"9543","DOI":"10.1038\/s41598-022-13580-9","volume":"12","author":"Y Teranishi","year":"2022","unstructured":"Teranishi, Y. et al. Early prediction of functional prognosis in neurofibromatosis type 2 patients based on genotype-phenotype correlation with targeted deep sequencing. Sci. Rep. 12, 9543 (2022).","journal-title":"Sci. Rep."},{"key":"33812_CR20","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1136\/jmg.2010.085241","volume":"48","author":"MJ Smith","year":"2011","unstructured":"Smith, M. J. et al. Cranial meningiomas in 411 neurofibromatosis type 2 (NF2) patients with proven gene mutations: Clear positional effect of mutations, but absence of female severity effect on age at onset. J. Med. Genet. 48, 261\u2013265 (2011).","journal-title":"J. Med. Genet."},{"key":"33812_CR21","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3171\/jns.2002.96.2.0217","volume":"96","author":"ME Baser","year":"2002","unstructured":"Baser, M. E., Makariou, E. V. & Parry, D. M. Predictors of vestibular schwannoma growth in patients with neurofibromatosis Type 2. J. Neurosurg. 96, 217\u2013222 (2002).","journal-title":"J. Neurosurg."},{"key":"33812_CR22","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3171\/jns.2002.96.2.0223","volume":"96","author":"VF Mautner","year":"2002","unstructured":"Mautner, V. F. et al. Vestibular schwannoma growth in patients with neurofibromatosis Type 2: A longitudinal study. J. Neurosurg. 96, 223\u2013228 (2002).","journal-title":"J. Neurosurg."},{"key":"33812_CR23","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1097\/MAO.0b013e3181b2364c","volume":"30","author":"LM Fisher","year":"2009","unstructured":"Fisher, L. M., Doherty, J. K., Lev, M. H. & Slattery, W. H. Concordance of bilateral vestibular schwannoma growth and hearing changes in neurofibromatosis 2: Neurofibromatosis 2 natural history consortium. Otol. Neurotol. 30, 835\u2013841 (2009).","journal-title":"Otol. Neurotol."},{"key":"33812_CR24","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1227\/NEU.0b013e31828bae28","volume":"72","author":"M Peyre","year":"2013","unstructured":"Peyre, M. et al. Conservative management of bilateral vestibular schwannomas in neurofibromatosis type 2 patients: hearing and tumor growth results. Neurosurgery 72, 907\u2013913 (2013).","journal-title":"Neurosurgery"},{"key":"33812_CR25","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1007\/s00405-014-3317-7","volume":"272","author":"G Kontorinis","year":"2015","unstructured":"Kontorinis, G. et al. Progress of hearing loss in neurofibromatosis type 2: Implications for future management. Eur. Arch. Otorhinolaryngol. 272, 3143\u20133150 (2015).","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"33812_CR26","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1097\/MAO.0000000000000239","volume":"35","author":"SR Plotkin","year":"2014","unstructured":"Plotkin, S. R., Merker, V. L., Muzikansky, A., Barker, F. G. & Slattery, W. Natural history of vestibular schwannoma growth and hearing decline in newly diagnosed neurofibromatosis type 2 patients. Otol. Neurotol. 35, 50\u201356 (2014).","journal-title":"Otol. Neurotol."},{"key":"33812_CR27","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1007\/BF00223872","volume":"95","author":"D Bourn","year":"1995","unstructured":"Bourn, D. et al. Eleven novel mutations in the NF2 tumour suppressor gene. Hum. Genet. 95, 572\u2013574 (1995).","journal-title":"Hum. Genet."},{"key":"33812_CR28","first-page":"314","volume":"55","author":"M MacCollin","year":"1994","unstructured":"MacCollin, M. et al. Mutational analysis of patients with neurofibromatosis 2. Am. J. Hum. Genet. 55, 314\u2013320 (1994).","journal-title":"Am. J. Hum. Genet."},{"key":"33812_CR29","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1227\/00006123-199510000-00022","volume":"37","author":"HK Ng","year":"1995","unstructured":"Ng, H. K. et al. Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors. Neurosurgery 37, 764\u2013773 (1995).","journal-title":"Neurosurgery"},{"key":"33812_CR30","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1136\/jnnp.66.6.764","volume":"66","author":"DG Evans","year":"1999","unstructured":"Evans, D. G. et al. Probability of bilateral disease in people presenting with a unilateral vestibular schwannoma. J. Neurol. Neurosurg. Psychiatry 66, 764\u2013767 (1999).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"33812_CR31","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1089\/gte.2004.8.368","volume":"8","author":"AJ Wallace","year":"2004","unstructured":"Wallace, A. J., Watson, C. J., Award, E., Evans, D. G. & Elles, R. G. Mutation scanning of the NF2 gene: An improved service based on meta-PCR\/sequencing, dosage analysis, and loss of heterozygosity analysis. Genet. Test 8, 368\u2013380 (2004).","journal-title":"Genet. Test"},{"key":"33812_CR32","unstructured":"Evans, D. G. Neurofibromatosis 2. GeneReviews https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1201\/ (1998(Updated 2018)"},{"key":"33812_CR33","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.otc.2011.12.005","volume":"45","author":"M Hoa","year":"2012","unstructured":"Hoa, M. & Slattery, W. H. 3rd. Neurofibromatosis 2. Otolaryngol. Clin. North Am. 45, 315\u2013332 (2012).","journal-title":"Otolaryngol. Clin. North Am."},{"key":"33812_CR34","doi-asserted-by":"publisher","first-page":"6216","DOI":"10.1038\/onc.2010.363","volume":"29","author":"KD Hadfield","year":"2010","unstructured":"Hadfield, K. D. et al. Rates of loss of heterozygosity and mitotic recombination in NF2 schwannomas, sporadic vestibular schwannomas and schwannomatosis schwannomas. Oncogene 29, 6216\u20136221 (2010).","journal-title":"Oncogene"},{"key":"33812_CR35","doi-asserted-by":"publisher","first-page":"5470","DOI":"10.1038\/srep5470","volume":"7","author":"H Chen","year":"2017","unstructured":"Chen, H., Xue, L., Wang, H., Wang, Z. & Wu, H. Differential NF2 gene status in sporadic vestibular schwannomas and its prognostic impact on tumour growth patterns. Sci. Rep. 7, 5470. https:\/\/doi.org\/10.1038\/srep5470 (2017).","journal-title":"Sci. Rep."},{"key":"33812_CR36","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/00129492-200501000-00017","volume":"26","author":"P Cay\u00e9-Thomasen","year":"2005","unstructured":"Cay\u00e9-Thomasen, P. et al. VEGF and VEGF receptor-1 concentration in vestibular schwannoma homogenates correlates to tumor growth rate. Otol. Neurotol. 26, 98\u2013101 (2005).","journal-title":"Otol. Neurotol."},{"key":"33812_CR37","doi-asserted-by":"publisher","first-page":"E340","DOI":"10.1002\/lary.24564","volume":"124","author":"NR London","year":"2014","unstructured":"London, N. R. & Gurgel, R. K. The role of vascular endothelial growth factor and vascular stability in diseases of the ear. Laryngoscope 124, E340-346 (2014).","journal-title":"Laryngoscope"},{"key":"33812_CR38","doi-asserted-by":"publisher","first-page":"18599","DOI":"10.1038\/srep18599","volume":"5","author":"S Dilwali","year":"2015","unstructured":"Dilwali, S., Landegger, L. D., Soares, V. Y., Deschler, D. G. & Stankovic, K. M. Secreted factors from human vestibular schwannomas can cause cochlear damage. Sci. Rep. 5, 18599. https:\/\/doi.org\/10.1038\/srep18599 (2015).","journal-title":"Sci. Rep."},{"key":"33812_CR39","first-page":"1498","volume":"18","author":"VY Soares","year":"2016","unstructured":"Soares, V. Y. et al. Extracellular vesicles derived from human vestibular schwannomas associated with poor hearing damage cochlear cells. Neuro. Oncol. 18, 1498\u20131507 (2016).","journal-title":"Neuro. Oncol."},{"key":"33812_CR40","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1038\/s41436-018-0384-y","volume":"21","author":"DG Evans","year":"2019","unstructured":"Evans, D. G. et al. Identifying the deficiencies of current diagnostic criteria for neurofibromatosis 2 using databases of 2777 individuals with molecular testing. Genet. Med. 21, 1525\u20131533 (2019).","journal-title":"Genet. Med."},{"key":"33812_CR41","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.jmoldx.2018.04.004","volume":"20","author":"R Fujiki","year":"2018","unstructured":"Fujiki, R. et al. Assessing the accuracy of variant detection in cost-effective gene panel testing by next-generation sequencing. J. Mol. Diagn. 20, 572\u2013582 (2018).","journal-title":"J. Mol. Diagn."},{"key":"33812_CR42","doi-asserted-by":"publisher","first-page":"1008643","DOI":"10.1371\/pgen1008643","volume":"16","author":"H Mutai","year":"2020","unstructured":"Mutai, H. et al. Variants encoding a restricted carboxy-terminal domain of SLC12A2 cause hereditary hearing loss in humans. PLoS Genet. 16, 1008643. https:\/\/doi.org\/10.1371\/pgen1008643 (2020).","journal-title":"PLoS Genet."},{"key":"33812_CR43","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards, S. et al. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet. Med. 17, 405\u2013424 (2015).","journal-title":"Genet. Med."},{"key":"33812_CR44","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1002\/humu.23626","volume":"39","author":"AN Abou Tayoun","year":"2018","unstructured":"Abou Tayoun, A. N. et al. Recommendations for interpreting the loss of function PVS1 ACM\/GAMP variant criterion. Hum. Mutat. 39, 1517\u20131524 (2018).","journal-title":"Hum. Mutat."},{"key":"33812_CR45","unstructured":"Van der Auwera, G. A. & O'Connor, B. D. Genomics in the Cloud: Using Docker, GATK, and WDL in Terra (1st Edition) (O'Reilly Media, 2020)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-33812-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-33812-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-33812-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,22]],"date-time":"2023-04-22T06:03:11Z","timestamp":1682143391000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-33812-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,22]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["33812"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-33812-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,22]]},"assertion":[{"value":"27 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6595"}}